In South Korea, “Quasi-Drugs” are defined as products that belong to one of the following three groups: 1) Fibers, rubber products or other similar products intended to be used for treating, reducing, or preventing diseases in human and animals, or 2) Non-equipment or non-machinery products that have minimal effect or do not have a direct effect on human, or other similar products, or 3) Products intended to be used for disinfection, insecticide or other similar purposes to prevent infectious diseases

About Global Regulatory Partners Inc:

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and South Korea GRP helps many life science companies register their products in different countries in compliance with local regulations.